Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | mRNA-4106 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on mRNA-4106 (Mar 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| mRNA-4106 | mRNA4106|mRNA 4106 | Limited information is currently available on mRNA-4106 (Mar 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06880549 | Phase I | mRNA-4106 mRNA-4106 + Nivolumab and relatlimab-rmbw | A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors | Recruiting | USA | 0 |